Surgalign Adds Medical Device Prototyping and Manufacturing Facility in San Diego
May 06 2021 - 4:00PM
Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical
technology company focused on elevating the standard of care
through the evolution of digital surgery, today announced it
has acquired the assets of a fully capable medical device machine
shop as a complement to its Spine Innovation Center operations in
greater San Diego. The current staff of the facility will join
Surgalign as employees. This acquisition gives the company the
ability to directly align its research and development operations
with a state-of-the-art prototyping and manufacturing capability to
accelerate and broaden new product development.
“We strongly believe this acquisition will lead to shortened
development times and superior products to better serve our
customers,” said Terry Rich, Surgalign’s president and chief
executive officer. “Being able to prototype new devices in-house
gives us better control of quality and should certainly strengthen
our product development engine, including our efforts to advance
the promise of digital surgery and all it could bring to spine
care. Adding this capability is another example of the significant
investment we are making to build a world-class digital surgery
operation in San Diego.”
The synergies from the acquisition will be recognized
immediately between both teams, accelerating Surgalign’s New
Product Introduction Process, and further solidifying the company’s
commitment to bringing customers solutions that deliver superior
clinical and economic outcomes.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company
committed to the promise of digital surgery and is building out its
digital surgery platform to drive transformation across the
surgical landscape. Uniquely aligned and resourced to advance
the standard of care, the company is building technologies
surgeons will look to for what is truly possible for their
patients. Surgalign is focused on bringing surgeons solutions that
predictably deliver superior clinical and economic outcomes.
Surgalign markets products throughout the United States and in
more than 50 countries worldwide through an expanding network of
top independent distributors. Surgalign, a member of AdvaMed, is
headquartered in Deerfield, IL, with commercial, innovation and
design centers in San Diego, CA, Marquette, MI, and Wurmlingen,
Germany. Learn more
at www.surgalign.com and connect on
LinkedIn and Twitter.
Forward Looking Statement
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These forward-looking statements are based on management’s
current expectations, estimates and projections about our industry,
our management's beliefs and certain assumptions made by our
management. Words such as "anticipates," "expects," "intends,"
"plans," "believes," "seeks," "estimates," variations of such words
and similar expressions are intended to identify such
forward-looking statements. These statements are not guarantees of
future performance and are subject to risks and uncertainties,
including the risks described in public filings with the U.S.
Securities and Exchange Commission (SEC). Our actual results may
differ materially from the anticipated results reflected in these
forward-looking statements. Copies of the company's SEC filings may
be obtained by contacting the company or the SEC or by visiting
Surgalign's website at www.surgalign.com or the SEC's
website at www.sec.gov.
Investor and Media Contact:Jonathon
Singerjsinger@surgalign.com+1 224 303 4651
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Apr 2023 to Apr 2024